Skip to main content
Top
Published in: BMC Public Health 1/2012

Open Access 01-12-2012 | Research article

Characteristics and treatment outcomes of tuberculosis patients who “transfer-in” to health facilities in Harare City, Zimbabwe: a descriptive cross-sectional study

Authors: Kudakwashe C Takarinda, Anthony D Harries, Tsitsi Mutasa-Apollo, Charles Sandy, Owen Mugurungi

Published in: BMC Public Health | Issue 1/2012

Login to get access

Abstract

Background

Zimbabwe is among the 22 Tuberculosis (TB) high burden countries worldwide and runs a well-established, standardized recording and reporting system on case finding and treatment outcomes. During TB treatment, patients transfer-out and transfer-in to different health facilities, but there are few data from any national TB programmes about whether this process happens and if so to what extent. The aim of this study therefore was to describe the characteristics and outcomes of TB patients that transferred into Harare City health department clinics under the national TB programme. Specific objectives were to determine i) the proportion of a cohort of TB patients registered as transfer-in, ii) the characteristics and treatment outcomes of these transfer-in patients and iii) whether their treatment outcomes had been communicated back to their respective referral districts after completion of TB treatment.

Methods

Data were abstracted from patient files and district TB registers for all transfer-in TB patients registered from January to December 2010 within Harare City. Descriptive statistics were calculated.

Results

Of the 7,742 registered TB patients in 2010, 263 (3.5%) had transferred-in: 148 (56%) were males and overall median age was 33 years (IQR, 26–40). Most transfer-in patients (74%) came during the intensive phase of TB treatment, and 58% were from rural health-facilities. Of 176 patients with complete data on the time period between transfer-in and transfer-out, only 85 (48%) arrived for registration in Harare from referral districts within 1 week of being transferred-out. Transfer-in patients had 69% treatment success, but in 21% treatment outcome status was not evaluated. Overall, 3/212 (1.4%) transfer-in TB patients had their TB treatment outcomes reported back to their referral districts.

Conclusion

There is need to devise better strategies of following up TB patients to their referral Directly Observed Treatment (DOT) centres from TB diagnosing centres to ensure that they arrive promptly and on time. Recording and reporting of information must improve and this can be done through training and supervision. Use of mobile phones and other technology to communicate TB treatment outcomes back to the referral districts would seem the obvious way to move forward on these issues.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organisation (WHO): Global Tuberculosis Control: WHO report 2011 WHO/HTM/TB 2011.16. 2011, Geneva: WHO World Health Organisation (WHO): Global Tuberculosis Control: WHO report 2011 WHO/HTM/TB 2011.16. 2011, Geneva: WHO
2.
go back to reference Zimbabwe National Statistics Agency (ZIMSTAT) ICF International: Zimbabwe Demographic and Health Survey 2010–11. 2012, Calverton: ZIMSTAT and ICF International Inc Zimbabwe National Statistics Agency (ZIMSTAT) ICF International: Zimbabwe Demographic and Health Survey 2010–11. 2012, Calverton: ZIMSTAT and ICF International Inc
3.
go back to reference Ministry of Health and Child Welfare: National Tuberculosis Guidelines. 2010, Harare: Ministry of Health and Child Welfare Ministry of Health and Child Welfare: National Tuberculosis Guidelines. 2010, Harare: Ministry of Health and Child Welfare
4.
go back to reference World Health Organization (WHO): Treatment of Tuberculosis Guidelines. 4th edition WHO/HTM/TB/2009.40. 2009, Geneva: WHO World Health Organization (WHO): Treatment of Tuberculosis Guidelines. 4th edition WHO/HTM/TB/2009.40. 2009, Geneva: WHO
5.
go back to reference World Health Organization (WHO): Global tuberculosis control: epidemiology, strategy, financing: WHO report 2009 WHO/HTM/TB/2009.411. 2009, Geneva: WHO World Health Organization (WHO): Global tuberculosis control: epidemiology, strategy, financing: WHO report 2009 WHO/HTM/TB/2009.411. 2009, Geneva: WHO
6.
go back to reference World Health Organization (WHO): Global tuberculosis Control 2010. WHO report 2010 WHO/HTM/TB/2010.7. 2010, Geneva: WHO World Health Organization (WHO): Global tuberculosis Control 2010. WHO report 2010 WHO/HTM/TB/2010.7. 2010, Geneva: WHO
7.
go back to reference Ministry of Health and Child Welfare: National Health Profile 2008. 2008, Harare: Ministry of Health and Child Welfare Ministry of Health and Child Welfare: National Health Profile 2008. 2008, Harare: Ministry of Health and Child Welfare
8.
go back to reference Takarinda KC, Harries AD, Srinath S, Mutasa-Apollo T, Sandy C, Mururungi O: Treatment outcomes of new adult tuberculosis patients in relation to HIV status in Zimbabwe. Public Health Action. 2011, 1 (Suppl 2): 34-39.CrossRefPubMedPubMedCentral Takarinda KC, Harries AD, Srinath S, Mutasa-Apollo T, Sandy C, Mururungi O: Treatment outcomes of new adult tuberculosis patients in relation to HIV status in Zimbabwe. Public Health Action. 2011, 1 (Suppl 2): 34-39.CrossRefPubMedPubMedCentral
9.
go back to reference Takarinda KC, Harries AD, Srinath S, Mutasa-Apollo T, Sandy C, Mururungi O: Treatment outcomes of adult patients with recurrent tuberculosis patients in relation to HIV status in Zimbabwe: a retrospective record review. BMC Public Health. 2012, 12: 124-10.1186/1471-2458-12-124.CrossRefPubMedPubMedCentral Takarinda KC, Harries AD, Srinath S, Mutasa-Apollo T, Sandy C, Mururungi O: Treatment outcomes of adult patients with recurrent tuberculosis patients in relation to HIV status in Zimbabwe: a retrospective record review. BMC Public Health. 2012, 12: 124-10.1186/1471-2458-12-124.CrossRefPubMedPubMedCentral
10.
go back to reference Mitchison DA: How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc Lung Dis. 1998, 2 (Suppl 1): 10-15.PubMed Mitchison DA: How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc Lung Dis. 1998, 2 (Suppl 1): 10-15.PubMed
11.
go back to reference Green A, Shaw J, Dimmock F, Conn C: A shared mission? Changing relationships between government and church health services in Africa. Int J Health Plann Mgmt. 2002, 17: 333-353. 10.1002/hpm.685.CrossRef Green A, Shaw J, Dimmock F, Conn C: A shared mission? Changing relationships between government and church health services in Africa. Int J Health Plann Mgmt. 2002, 17: 333-353. 10.1002/hpm.685.CrossRef
13.
go back to reference Meijnen S, Weismuller MM, Claessens NJM, Kwanjana JH, Salaniponi FM, Harries AD: Outcome of patients with tuberculosis who transfer between reporting units. Int J Tuberc Lung Dis. 2002, 6 (Suppl 8): 666-671.PubMed Meijnen S, Weismuller MM, Claessens NJM, Kwanjana JH, Salaniponi FM, Harries AD: Outcome of patients with tuberculosis who transfer between reporting units. Int J Tuberc Lung Dis. 2002, 6 (Suppl 8): 666-671.PubMed
Metadata
Title
Characteristics and treatment outcomes of tuberculosis patients who “transfer-in” to health facilities in Harare City, Zimbabwe: a descriptive cross-sectional study
Authors
Kudakwashe C Takarinda
Anthony D Harries
Tsitsi Mutasa-Apollo
Charles Sandy
Owen Mugurungi
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2012
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-12-981

Other articles of this Issue 1/2012

BMC Public Health 1/2012 Go to the issue